Institutional Biosafety Committee

Dr. Robert McLean, Regents Professor, Biology, Chair

Dr. Nihal Dharmasiri, Associate Professor, Biology
Mr. David Erb, Non-institutional Member
Dr. Hong GuKang, Assistant Professor, Biology
Mr. Roger Hull, R.N., Non-institutional Member
Dr. Kevin (Lysle) Lewis, Associate Professor, Chemistry and Biochemistry
Dr. Rodney Rohde, Program Chair and Professor, Clinical Laboratory Science and Associate Dean, College of Health Professions 

Ex Officio:
Dr. Michael Blanda, Assistant Vice President, Research and Federal Relations (T)
Ms. Elsie Romano, Biological Safety Specialist, Environmental Health, Safety, and Risk Management (T)
Ms. Szende Smith, Compliance Specialist, Associate Vice President, Research

Institutional Biosafety Committee (IBCs) were established under the NIH Guidelines for Research Involving Recombinant DNA Molecules to provide local review and oversight of nearly all forms of research utilizing recombinant DNA. Over time, many institutions have chosen to assign their IBCs the responsibility of reviewing a variety of experimentation that involves biological materials (e.g., infectious agents) and other potentially hazardous agents (e.g., carcinogens).